CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation Cardiopulmonary Exercise Testing: What Is its Value? Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design Volume brings value

Original Research2016 Jul 19;68(3):313-321.

JOURNAL:J Am Coll Cardiol. Article Link

Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines

Rodriguez F, Mahaffey KW. Keywords: acute coronary syndrome; anticoagulants; antiplatelet; quality of care; risk assessment

FULL TEXT PDF